Medical Oncology

Papers
(The H4-Index of Medical Oncology is 19. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-03-01 to 2024-03-01.)
ArticleCitations
Steps in metastasis: an updated review130
Activation of the HGF/c-MET axis promotes lenvatinib resistance in hepatocellular carcinoma cells with high c-MET expression66
Cancer treatment during COVID-19 pandemic52
Delta-radiomics increases multicentre reproducibility: a phantom study47
Exosomes and cancer: from molecular mechanisms to clinical applications47
Combating TKI resistance in CML by inhibiting the PI3K/Akt/mTOR pathway in combination with TKIs: a review32
Will traditional biopsy be substituted by radiomics and liquid biopsy for breast cancer diagnosis and characterisation?31
An updated review of epidemiology, risk factors, and management of male breast cancer31
Strategies for having a more effective and less toxic CAR T-cell therapy for acute lymphoblastic leukemia30
Myths and facts about artificial intelligence: why machine- and deep-learning will not replace interventional radiologists29
Artificial Intelligence in radiotherapy: state of the art and future directions29
Cancer and COVID-19: Why are cancer patients more susceptible to COVID-19?28
COVID-19 and cancer care: what do international guidelines say?24
Neuroendocrine breast carcinoma: a rare but challenging entity24
Targeting of oncogenic signaling pathways by berberine for treatment of colorectal cancer23
Circular RNAs and their participation in stemness of cancer23
MicroRNAs and target molecules in bladder cancer23
The anti-angiogenic agent lenvatinib induces tumor vessel normalization and enhances radiosensitivity in hepatocellular tumors23
Extracellular vesicle isolation from human renal cancer tissue22
Associated analysis of PER1/TUBB2B with endometrial cancer development caused by circadian rhythm disorders19
Cancer stem cells in colorectal cancer and the association with chemotherapy resistance19
Bexarotene inhibits cell proliferation by inducing oxidative stress, DNA damage and apoptosis via PPARγ/ NF-κB signaling pathway in C6 glioma cells19
Luteolin and cancer metastasis suppression: focus on the role of epithelial to mesenchymal transition19
Comparative bioinformatical analysis of pancreatic head cancer and pancreatic body/tail cancer19
0.5107319355011